AB
CTKB icon

Amalgamated Bank’s Cytek Biosciences CTKB Stock Holding History

Amalgamated Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,901
Closed -$139K – 1643
2026
Q1 		$139K Sell
31,901
-535
-2% -$2.53K ﹤0.01% 1592
2025
Q4 		$164K Buy
32,436
+502
+2% +$2.33K ﹤0.01% 1607
2025
Q3 		$111K Buy
31,934
+2,003
+7% +$7.52K ﹤0.01% 1682
2025
Q2 		$102K Buy
29,931
+715
+2% +$2.38K ﹤0.01% 1690
2025
Q1 		$117K Sell
29,216
-2,626
-8% -$13.6K ﹤0.01% 1642
2024
Q4 		$207K Buy
31,842
+964
+3% +$5.74K ﹤0.01% 1568
2024
Q3 		$171K Buy
30,878
+1,608
+5% +$9.12K ﹤0.01% 1610
2024
Q2 		$163K Sell
29,270
-3,593
-11% -$21.6K ﹤0.01% 1622
2024
Q1 		$221K Sell
32,863
-10,654
-24% -$84.3K ﹤0.01% 1576
2023
Q4 		$397K Sell
43,517
-4,971
-10% -$31.3K ﹤0.01% 1531
2023
Q3 		$268K Buy
48,488
+5,957
+14% +$47.8K ﹤0.01% 1672
2023
Q2 		$363K Buy
42,531
+26,599
+167% +$239K ﹤0.01% 1582
2023
Q1 		$146K Sell
15,932
-2,394
-13% -$25.8K ﹤0.01% 1913
2022
Q4 		$187K Hold
18,326
– – ﹤0.01% 1886
2022
Q3 		$270K Buy
18,326
+291
+2% +$3.78K ﹤0.01% 1726
2022
Q2 		$194K Buy
18,035
+2,810
+18% +$28K ﹤0.01% 1894
2022
Q1 		$164K Buy
+15,225
New +$206K ﹤0.01% 2016

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Amalgamated Bank's CTKB Position: Q2 2026 in Review

Amalgamated Bank sold out of Cytek Biosciences (CTKB) in Q2 2026, closing a stake of 31,901 shares — an estimated $139K sold.

Amalgamated Bank first reported a position in CTKB in Q1 2022 and held it in 17 quarters. The position peaked at $397K in Q4 2023. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Amalgamated Bank reported no remaining Cytek Biosciences position as of Q2 2026 after selling out during the quarter.
  • Amalgamated Bank sold 31,901 Cytek Biosciences shares in Q2 2026, an estimated $139K.
  • Amalgamated Bank first reported a position in Cytek Biosciences in Q1 2022 and held it in 17 quarters.
  • Amalgamated Bank's Cytek Biosciences position peaked at $397K in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.